Senthil Ranganathan, PhD
VP, Head of Technical Operations, Stem Cell Therapy & Regenerative Medicine
Athersys
Country or State
United States
Bio
CMC strategy for development, manufacture, validation and commercialization of biologics (cell and gene therapies, vaccines, mAbs, Antibody-Drug Conjugates (ADCs), enzyme therapies, blood plasma products) management of global CMOs, CMC regulatory strategy and filing, pre-approval regulatory inspections, risk management, post-approval life cycle management
Similar Speakers
Current Position
VP, Head of Technical Operations, Stem Cell Therapy & Regenerative Medicine at Athersys
Degrees
Post doctoral fellow, Biophysics / Virology